// App-Quantinova.ai

1263 : UCHL1 modulates uterine papillary serous cancer progression through interaction with cyclin B1

Researchers

Presenter

  • Suet Ying Kwan

Principal Investigators

  • Samuel C. Mok

  • Rosemarie E. Schmandt

  • Kwong-Kwok Wong

  • Karen H. Lu

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

  • Solid malignancies

Biomarkers

  • Aurora kinase A

  • Ubiquitin

Drug/Treatment

  • Doxycycline

  • Paclitaxel

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved